Atlas Trials

Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients

Clinical trial NCT03382587 · COMPLETED

Trial details

NCT number
NCT03382587
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Wet Age-related Macular Degeneration
Start date
2017-12-05
Primary completion
2018-11-09
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.